Systemic lupus erythematosus – Life with Disease

Go back

Systemic lupus erythematosus (SLE), commonly known as lupus, is a chronic autoimmune condition that can affect many parts of the body. While it presents unique challenges, understanding what to expect and how to manage the disease can help patients and their families navigate the journey with greater confidence and hope.

Understanding the Outlook: What the Future May Hold

When someone receives a diagnosis of systemic lupus erythematosus, one of the first questions that naturally arises is: “What does this mean for my future?” It’s important to understand that lupus affects each person differently, and the outlook varies greatly depending on how the disease manifests and how early treatment begins. The good news is that advances in medical care have dramatically improved outcomes for people living with lupus over the past several decades.

Today, more than 90% of people with lupus can expect to live normal, healthy lives with appropriate treatment and management. This represents a remarkable shift from earlier times when the disease posed much greater risks. In 1955, the five-year survival rate for lupus patients was only about 53%, but now the ten-year survival rate exceeds 90%. This transformation reflects not only better understanding of the disease but also the development of more effective treatments and earlier diagnosis.

However, lupus remains a serious condition that requires ongoing medical attention. The disease follows an unpredictable pattern of flares, which are periods when symptoms worsen, alternating with periods of remission, when symptoms improve or disappear. Some people experience mild disease with occasional symptoms that are relatively easy to control, while others face more severe complications affecting vital organs like the kidneys, heart, or brain. The severity of lupus can influence long-term outcomes, with more aggressive disease requiring more intensive treatment approaches.

Several factors can influence a person’s prognosis with lupus. Getting diagnosed early and starting treatment promptly improves outcomes significantly. Access to regular medical care, following treatment plans carefully, and making healthy lifestyle choices all contribute to better long-term health. On the other hand, delays in diagnosis, lack of access to healthcare, and not following treatment recommendations can lead to more complications and poorer outcomes.

⚠️ Important
The outlook for lupus has improved dramatically, but this progress depends heavily on early diagnosis and consistent treatment. If you notice symptoms like persistent joint pain, unexplained rashes, extreme fatigue, or fever without an obvious cause, it’s essential to see a healthcare provider promptly. Early intervention can make a significant difference in preventing organ damage and improving long-term quality of life.

How Lupus Progresses Without Treatment

Understanding what happens when lupus goes untreated or is poorly managed helps illustrate why medical care is so crucial. Lupus is not a disease that simply stays the same or goes away on its own. Instead, without proper treatment, the condition tends to progress and cause increasing damage to various body systems over time.

In its natural course, untreated lupus typically causes chronic inflammation throughout the body. This inflammation is the body’s immune system mistakenly attacking its own healthy tissues, thinking they are foreign invaders. When this immune response continues unchecked, it gradually damages the affected organs and tissues. What might start as joint pain and fatigue can evolve into more serious problems affecting the kidneys, heart, lungs, blood vessels, and nervous system.

The kidneys are particularly vulnerable in lupus. A condition called lupus nephritis, which is inflammation of the kidneys, can develop in up to 60% of people with systemic lupus erythematosus, usually within the first five years after symptoms begin. Without treatment, lupus nephritis can progress to chronic kidney disease or even kidney failure, which may require dialysis or transplantation. The kidneys gradually lose their ability to filter waste from the blood, leading to a buildup of toxins in the body.

The cardiovascular system also suffers from untreated lupus. Chronic inflammation damages blood vessels, increasing the risk of atherosclerosis (hardening of the arteries), which can lead to heart attacks and strokes at younger ages than in the general population. The heart itself can be affected, with inflammation of the heart muscle (myocarditis) or the sac surrounding the heart (pericarditis). These complications can impair the heart’s ability to pump blood effectively.

In the nervous system, untreated lupus may cause a range of problems from mild headaches to serious complications like seizures, strokes, memory problems, and mood disorders. More than one in five people with lupus experience neuropsychiatric symptoms affecting the brain and nervous system. The blood system can also be affected, with the immune system destroying red blood cells, white blood cells, or platelets, leading to anemia, increased infection risk, or bleeding problems.

The progressive nature of untreated lupus means that damage accumulates over time, and some of this damage can become permanent. This is why early diagnosis and consistent treatment are so important—they can prevent or minimize this progression and preserve organ function.

Possible Complications and Unexpected Challenges

Even with treatment, people with lupus may experience complications that require additional attention and care. Understanding these potential complications helps patients and families recognize warning signs early and seek help promptly.

Kidney complications are among the most serious concerns in lupus. Lupus nephritis can develop silently, meaning that significant kidney damage may occur before any symptoms appear. This is why regular urine tests and blood tests to check kidney function are essential for everyone with lupus. Signs of kidney involvement may include swelling in the legs or ankles, high blood pressure, changes in urination patterns, or foamy urine. If caught early, kidney damage can often be controlled or even reversed with appropriate treatment.

Cardiovascular complications extend beyond heart disease to include problems with blood clotting. Some people with lupus develop antiphospholipid syndrome, a condition that increases the risk of dangerous blood clots in veins and arteries. These clots can lead to strokes, heart attacks, deep vein thrombosis, or pregnancy complications. The syndrome requires specific treatment with blood-thinning medications to prevent life-threatening events.

Lung complications can range from inflammation of the lining around the lungs (pleurisy), which causes chest pain when breathing, to more serious problems like fluid buildup around the lungs, lung inflammation (pneumonitis), pulmonary hypertension (high blood pressure in the lung arteries), or scarring of lung tissue (interstitial lung disease). These complications can cause shortness of breath, chest pain, or persistent cough.

Infections pose a significant risk for people with lupus because both the disease itself and many of the medications used to treat it suppress the immune system. This makes it easier for bacteria, viruses, and other germs to cause infections. Common infections like colds and flu can become more severe, and some infections that rarely affect healthy people may occur. Pneumonia and urinary tract infections are particularly common. Staying up to date with vaccinations and seeking prompt medical care for signs of infection are crucial preventive measures.

Blood disorders can complicate lupus management. Autoimmune hemolytic anemia occurs when the immune system destroys red blood cells faster than the body can replace them, leading to fatigue and weakness. Low platelet counts (thrombocytopenia) increase bleeding risk, while low white blood cell counts make infections more likely. Regular blood tests help monitor these conditions.

Bone health can deteriorate in people with lupus, particularly those taking corticosteroids long-term. Osteoporosis, or thinning of the bones, increases fracture risk. Additionally, some people develop a condition called avascular necrosis, where blood flow to bones is reduced, causing bone tissue to die and collapse. This most commonly affects the hip and can require joint replacement surgery.

Mental health complications, including depression and anxiety, are common in lupus. These may result from the chronic stress of living with a serious illness, from the direct effects of inflammation on the brain, or from medications used to treat the disease. Depression and anxiety deserve the same attention as physical symptoms and should be discussed openly with healthcare providers.

Impact on Daily Life and Activities

Living with lupus touches nearly every aspect of daily life, from the moment someone wakes up to how they plan their work, relationships, and leisure activities. Understanding these impacts helps patients develop strategies to maintain quality of life while managing their condition.

Fatigue is perhaps the most pervasive symptom affecting daily life for people with lupus. This isn’t ordinary tiredness that improves with rest; it’s an overwhelming exhaustion that can make even simple tasks feel impossible. Someone with lupus might wake up feeling as tired as when they went to bed, despite sleeping through the night. This fatigue can make it difficult to maintain employment, keep up with household responsibilities, or participate in social activities. Many people find they need to carefully budget their energy, prioritizing essential activities and learning to pace themselves throughout the day.

Physical activities and exercise require a delicate balance with lupus. While regular, moderate exercise is beneficial and recommended for maintaining overall health, joint pain, muscle weakness, and fatigue can make it challenging. The key is finding activities that provide benefits without triggering flares. Swimming and water exercises are often ideal because water supports the body and reduces stress on joints. Walking, gentle yoga, and tai chi can also be beneficial. However, people with lupus need to listen to their bodies and adjust activity levels during flares when rest becomes more important.

Work life often requires significant adjustments. The unpredictability of lupus flares can make it difficult to maintain regular work schedules or meet consistent performance expectations. Some people find they need to reduce their hours, change to less physically demanding positions, or explore flexible work arrangements like telecommuting. In the United States, people with lupus are protected under the Americans with Disabilities Act, which requires employers to provide reasonable accommodations. These might include flexible scheduling, the ability to work from home during flares, extra breaks, or adjusted physical tasks.

Social relationships and activities can become complicated by lupus. The unpredictability of the disease means that plans may need to be cancelled at the last minute when a flare occurs. Fatigue may limit the ability to attend social gatherings, and sensitivity to sunlight may require avoiding outdoor activities or taking extra precautions. Some people find that friends and family members who don’t understand the disease may become frustrated or unsupportive when plans change repeatedly. Building a support network of understanding people and connecting with others who have lupus can help reduce feelings of isolation.

Sun exposure requires vigilance because ultraviolet light can trigger lupus flares and worsen symptoms. This means more than just avoiding the beach on sunny days—it requires year-round sun protection, even on cloudy days and when indoors near windows. People with lupus typically need to use high-SPF sunscreen (at least SPF 50), wear protective clothing including long sleeves and wide-brimmed hats, seek shade, and plan outdoor activities for early morning or late afternoon when UV rays are weaker. Fluorescent lights can also be problematic for some people.

Emotional and mental well-being face significant challenges with lupus. The chronic nature of the disease, the unpredictability of flares, the visible changes like rashes and hair loss, and the limitations it imposes can lead to feelings of grief, frustration, anxiety, and depression. Many people struggle with changes to their identity and self-image, particularly when lupus interferes with roles they valued, such as being an active parent, a productive worker, or a social butterfly. Seeking support from mental health professionals, support groups, or counselors who understand chronic illness can be invaluable.

Practical coping strategies can help manage these daily challenges. Learning to recognize early warning signs of a flare allows people to adjust activities and seek medical attention before symptoms become severe. Developing routines that prioritize rest, healthy eating, stress reduction, and medication adherence provides a stable foundation. Using assistive devices like jar openers or shower stools during flares can help maintain independence. Planning ahead for activities by ensuring adequate rest beforehand and allowing recovery time afterward helps prevent overexertion.

⚠️ Important
Living well with lupus requires accepting the need for adjustments while refusing to let the disease completely define your life. It’s okay to ask for help, to change plans when necessary, and to prioritize your health. Small daily choices—like wearing sunscreen, taking medications as prescribed, getting enough rest, and managing stress—accumulate to make a significant difference in disease control and quality of life.

Supporting Family Members Through Clinical Trials

For families dealing with systemic lupus erythematosus, understanding clinical trials can open doors to new treatment possibilities and contribute to advancing medical knowledge that helps future patients. Clinical trials are research studies that test new treatments, medications, or approaches to managing lupus. Participating in these trials is an important personal decision that families should approach with both optimism and careful consideration.

Clinical trials for lupus are testing various approaches, from new medications that target specific parts of the immune system to innovative therapies like cell-based treatments. Recent years have seen exciting developments, including the approval of new biological medications that offer hope for patients who haven’t responded well to traditional treatments. Trials are also exploring better ways to diagnose lupus earlier, predict which patients might develop serious complications, and personalize treatment based on individual characteristics.

Family members can play a crucial supportive role when a loved one is considering or participating in a clinical trial. The first step is helping gather information about available trials. Resources for finding lupus trials include the Lupus Foundation of America, which maintains information about ongoing research; the National Institutes of Health’s clinical trials database; and asking the patient’s rheumatologist about trials for which they might be eligible. Healthcare providers often know about trials at their institutions or can refer patients to research centers conducting lupus studies.

Once potential trials are identified, families can help by attending informational sessions or appointments where the trial is explained. Having a supportive person present helps ensure that all questions are asked and important information is remembered. Families should encourage their loved one to fully understand what participation involves, including how often visits are required, what tests or procedures will be done, potential risks and benefits, and whether there are costs involved. Most trials cover the cost of the experimental treatment and related care, but it’s important to clarify this upfront.

Understanding the informed consent process is crucial. Before joining a trial, participants receive detailed information about the study and must sign a consent form. Family members can help by reviewing this document together, making sure all concerns are addressed, and understanding that participation is always voluntary—patients can withdraw from a trial at any time without affecting their regular medical care.

Practical support makes trial participation easier. Clinical trials often require frequent visits to the research center, which may involve travel and time away from work or other responsibilities. Families can help by providing transportation, accompanying the patient to appointments, helping track appointments and medications, and assisting with any paperwork or questionnaires required by the study. Keeping a journal of how the patient is feeling, any side effects experienced, and questions that arise between visits can be valuable.

Emotional support is equally important. Participating in a trial can bring both hope and anxiety. There may be uncertainty about whether the treatment will work, fear about potential side effects, or disappointment if the patient receives a placebo rather than the active treatment. Family members can provide encouragement, help maintain perspective, and remind the patient that even if a particular treatment doesn’t help them personally, their participation contributes valuable knowledge that may help others with lupus in the future.

Communication with the research team should be open and ongoing. Families can help ensure that any new symptoms, side effects, or concerns are reported promptly to study coordinators. They can also help advocate for the patient if any issues arise during the trial, such as difficulty getting to appointments or concerns about how the study is being conducted.

It’s important for families to maintain realistic expectations about clinical trials. Not all experimental treatments prove effective, and some may have side effects that make them unsuitable for widespread use. However, trials are conducted with careful safety monitoring, and participants often receive more frequent and detailed medical attention than they would in routine care. The knowledge gained from trials—both successful and unsuccessful—advances the field and brings us closer to better treatments for everyone with lupus.

Finally, families should ensure that participating in a trial doesn’t mean neglecting established care. Patients should continue seeing their regular healthcare providers, taking any prescribed medications not related to the trial, and maintaining healthy lifestyle habits. Clinical trial participation should complement, not replace, comprehensive lupus management.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Hydroxychloroquine – An antimalarial medication recommended for all patients with lupus to prevent flares, reduce organ damage, decrease thrombosis risk, and increase long-term survival
  • Prednisone (and other corticosteroids) – Used to reduce inflammation and suppress the immune system; low doses may be used for skin and arthritis symptoms, while higher doses are reserved for more severe organ involvement
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) – Used to treat joint pain, swelling, and pleurisy symptoms in mild lupus
  • Belimumab (Saphnelo) – A biologic medication that was the first drug approved specifically for lupus in over 50 years; it targets specific immune pathways involved in the disease
  • Anifrolumab – A newer biologic medication approved in 2021 for the management of systemic lupus erythematosus
  • Rituximab – A biologic medication used in lupus treatment that targets B cells in the immune system
  • Voclosporin (Lupkynis) – A newer medication approved in 2021, specifically for lupus nephritis (kidney involvement)

Ongoing Clinical Trials on Systemic lupus erythematosus

  • Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

    Not yet recruiting

    1 1 1 1
    Sweden
  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    1 1
    Investigated drugs:
    Bulgaria Greece Poland Romania Spain
  • Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

    Not recruiting

    1 1 1
    Investigated diseases:
    Bulgaria Czechia Hungary Poland Portugal Slovakia +1
  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Greece Poland Spain Sweden
  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Germany Hungary Italy The Netherlands +1
  • Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

    Not recruiting

    1 1 1
    Czechia Germany Hungary Italy The Netherlands Poland +1
  • Study of Belimumab for Children with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Spain
  • Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia France Italy Poland Spain
  • Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Hungary Poland Spain
  • Study on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus

    Not recruiting

    1 1 1
    France Germany Spain

References

https://medlineplus.gov/ency/article/000435.htm

https://www.lupus.org/resources/what-is-systemic-lupus-erythematosus-sle

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://www.ncbi.nlm.nih.gov/books/NBK535405/

https://www.mayoclinic.org/diseases-conditions/lupus/symptoms-causes/syc-20365789

https://emedicine.medscape.com/article/332244-overview

https://www.cdc.gov/lupus/about/index.html

https://www.nm.org/conditions-and-care-areas/rheumatology/systemic-lupus-erythematosus-sle

https://www.nhs.uk/conditions/lupus/

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://www.mayoclinic.org/diseases-conditions/lupus/diagnosis-treatment/drc-20365790

https://www.aafp.org/pubs/afp/issues/2023/0400/systemic-lupus-erythematosus.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10261264/

https://medlineplus.gov/ency/article/000435.htm

https://emedicine.medscape.com/article/332244-treatment

https://www.lupus.org/news/american-college-of-rheumatology-new-systemic-lupus-erythematosus-guideline

https://www.nature.com/articles/s41573-025-01242-0

https://www.lupus.org/resources/dos-and-donts-for-living-well-with-lupus

https://my.clevelandclinic.org/health/diseases/4875-lupus

https://arthritissj.com/helping-patients-with-sle-thrive-tips-for-living-better-with-lupus/

https://womenshealth.gov/lupus/living-lupus

https://www.parkview.com/blog/how-to-care-for-yourself-when-you-have-lupus

https://www.cdc.gov/lupus/about/index.html

https://www.bassmedicalgroup.com/blog-post/coping-strategies-for-living-with-lupus

https://www.webmd.com/lupus/lupus-tips-everyday-living

https://rheumatology.org/patient-blog/lupus-self-management-take-back-control

FAQ

Can lupus be cured?

There is currently no cure for lupus. However, with proper treatment and management, the disease can be controlled effectively, allowing most people with lupus to live normal, healthy lives. The goal of treatment is to achieve remission (no symptoms) or at least low disease activity, prevent flares, and minimize organ damage.

Is lupus contagious or hereditary?

Lupus is not contagious—you cannot catch it from someone else. However, genetics do play a role. If you have a close family member with lupus, your risk of developing it is slightly higher than the general population, though most people with lupus do not have family members with the disease. Having a family history increases risk but doesn’t guarantee you’ll develop lupus.

What triggers lupus flares?

Common lupus flare triggers include too much sun or UV light exposure, stress, overwork, lack of sleep, infections, injury, stopping lupus medications, certain other medications, and exposure to fluorescent or halogen lights. Triggers vary from person to person, so learning your individual triggers through careful observation can help you prevent or minimize flares.

How often do I need to see my doctor if I have lupus?

The frequency of doctor visits depends on your disease activity. Patients with active disease should be evaluated every one to three months, with regular blood pressure measurements, blood tests (including anti-double-stranded DNA antibodies and complement levels), urinalysis, complete blood count, and kidney and liver function tests. Even when symptoms are mild or absent, regular monitoring is essential because lupus can be active in silent ways that only laboratory tests can detect.

Can I work if I have lupus?

Many people with lupus are able to work, though some may need adjustments or accommodations. The unpredictability of flares can make maintaining regular schedules challenging. In the United States, people with lupus are protected under the Americans with Disabilities Act, which requires employers to provide reasonable accommodations such as flexible scheduling, work-from-home options, extra breaks, or reduced physical demands. Some people may need to reduce hours or change positions, but many successfully maintain employment with proper disease management and workplace support.

🎯 Key takeaways

  • More than 90% of people with lupus now live normal, healthy lives with proper treatment—a dramatic improvement from survival rates of just 53% at five years in 1955
  • Hydroxychloroquine is recommended for all lupus patients because it prevents flares, reduces organ damage, and has been shown to prolong life
  • Lupus nephritis (kidney inflammation) can develop silently in up to 60% of people with lupus, making regular urine and blood tests essential even when feeling well
  • The disease affects women nearly 10 times more often than men and is more common in African American, Hispanic, Asian American, and Native American populations
  • Sunlight can trigger lupus flares, requiring year-round sun protection with SPF 50 or higher sunscreen, protective clothing, and avoiding peak sun hours
  • New biologic medications like belimumab and anifrolumab represent significant advances, offering the first new treatment options approved for lupus in over 50 years
  • Early diagnosis and consistent treatment are crucial for preventing permanent organ damage and improving long-term outcomes
  • Fatigue is one of the most common and challenging symptoms, requiring careful energy management and pacing of daily activities rather than simply pushing through tiredness